Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study

BACKGROUND: Real-world data on chemotherapy-naïve patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone plus prednisone are limited, largely deriving from small retrospective studies. METHODS: ABitude is an Italian, observational, prospective, multicenter stu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Adv Med Oncol
Hlavní autoři: Procopio, Giuseppe, Chiuri, Vincenzo Emanuele, Giordano, Monica, Mantini, Giovanna, Maisano, Roberto, Bordonaro, Roberto, Calvani, Nicola, Facchini, Gaetano, De Placido, Sabino, Airoldi, Mario, Sbrana, Andrea, Gasparro, Donatello, Ludovico, Giuseppe Mario, Guglielmini, Pamela, Naglieri, Emanuele, Fagnani, Daniele, Aglietta, Massimo, Schips, Luigi, Beccaglia, Patrizia, Sciarra, Alessandro, Livi, Lorenzo, Santini, Daniele
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7604981/
https://ncbi.nlm.nih.gov/pubmed/33193831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920968725
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky